Antipsychotic Polypharmacy

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|10|18|2231-2238

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.10, Iss.18, 2004-07, pp. : 2231-2238

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Safety and tolerability of antipsychotic polypharmacy

By Gallego Juan A   Nielsen Jimmi   De Hert Marc   Kane John M   Correll Christoph U  

Expert Opinion on Drug Safety, Vol. 11, Iss. 4, 2012-07 ,pp. : 527-542

Informa Healthcare

Access to resources Recommend Favorite

Antipsychotic polypharmacy in schizophrenia in Canada

By  

Inpharma, Vol. 1, Iss. 1296, 2001-01 ,pp. : 7-7

Adis International

Access to resources Recommend Favorite

Antipsychotic Polypharmacy in Schizophrenia: Benefits and Risks

By Barnes Thomas R.E.   Paton Carol  

CNS Drugs, Vol. 25, Iss. 5, 2011-05 ,pp. : 383-399

Adis International

Access to resources Recommend Favorite

Antipsychotic polypharmacy determined by severity of psychosis

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 494, 2006-01 ,pp. : 8-8

Adis International

Access to resources Recommend Favorite

Antipsychotic Polypharmacy: Still Dirty, But Hardly a Secret. A Systematic Review and Clinical Guide

By K. Tracy Derek   Sendt Kyra-Verena   S. Shergill Sukhwinder  

Current Psychopharmacology, Vol. 2, Iss. 2, 2013-05 ,pp. : 143-171

Bentham Science Publishers

Access to resources Recommend Favorite